Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery

Research output: Contribution to journalJournal articleResearchpeer-review

Michael Taulo Lund, Merethe Hansen, Stinna Skaaby, Sina Dalby, Mikael Støckel, Andrea Karen Floyd, Karsten Bech, Jørn Wulff Helge, Jens Juul Holst, Flemming Dela

INTRODUCTION: A major part of the patients with type 2 diabetes (T2DM) show remission after Roux-en-Y gastric bypass (RYGB). This is the result of increased postoperative insulin sensitivity and β-cell secretion. The aim of the present study was to elucidate the importance of the preoperative β-cell function in T2DM for the chance of remission after RYGB.

METHODS: 15 patients with and 18 without T2DM had 25 g oral (OGTT) and intravenous (IVGTT) glucose tolerance tests performed at inclusion, after a diet induced weight loss, and 4 and 18 months after RYGB.

RESULTS: Postoperative first phase insulin secretion rate (ISR) during the IVGTT and β-cell glucose sensitivity during the OGTT increased in T2DM. Postoperative insulin sensitivity and the disposition index (DI) markedly increased in both groups. By stratifying the T2DM into two groups according to highest (T2DMhigh ) and lowest (T2DMlow ) baseline DI, a restoration of first phase ISR and β-cell glucose sensitivity were seen only in T2DMhigh . Remission of type 2 diabetes was 71 and 38% in T2DMhigh and T2DMlow , respectively. Postoperative postprandial GLP-1 concentrations increased markedly, but did not differ between the groups.

CONCLUSION: Our findings emphasize the importance of the preoperative of β-cell function for remission of diabetes after RYGB. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalThe Journal of Physiology
Volume593
Issue number14
Pages (from-to)3123-33
Number of pages11
ISSN0022-3751
DOIs
Publication statusPublished - 13 Apr 2015

ID: 135415785